Koichi Enomoto

Title: Koichi Enomoto: Innovator in Protein Biotechnology

Introduction

Koichi Enomoto is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of proteins for pharmaceutical applications. With a total of 3 patents, his work focuses on innovative processes for preparing proteins that have therapeutic potential.

Latest Patents

Enomoto's latest patents include a groundbreaking protein derived from human MP52. This protein has an amino acid sequence detailed in SEQ ID No.:1 of the Sequence Listing. The patent describes a homodimer protein that can be obtained through a series of steps, including constructing a plasmid, transforming it, solubilizing inclusion bodies, purifying the monomer protein, and refolding it into a dimer protein. This homodimer protein is particularly useful as a pharmaceutical composition for treating cartilage and bone diseases.

Career Highlights

Throughout his career, Koichi Enomoto has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH. His expertise in protein biotechnology has positioned him as a key figure in the development of innovative therapeutic solutions.

Collaborations

Enomoto has collaborated with several professionals in his field, including Fusao Makishima and Hiroyuki Takamatsu. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Koichi Enomoto's contributions to protein biotechnology highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to addressing significant medical challenges through scientific advancements.